Amgen Highlights Pipeline at TD Cowen Conference
THOUSAND OAKS, Calif., February 24, 2026 Amgen announced it will present at the 46th Annual TD Cowen Health Care...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
THOUSAND OAKS, Calif., February 24, 2026 Amgen announced it will present at the 46th Annual TD Cowen Health Care...
NEW YORK, Feb. 24, 2026 — Bristol Myers Squibb announced its participation in the upcoming TD Cowen 46th Annual...
KING OF PRUSSIA, PENNSYLVANIA | January 26, 2026 — Phio Pharmaceuticals has announced its participation in the Third Annual...
CHICAGO, Dec. 29, 2025 — GE HealthCare announced that its senior management team will present at an upcoming January...
Dateline — SALT LAKE CITY, November 11, 2025:Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostic testing...
Fremont, Calif. – November 6, 2025 Cytek Biosciences, Inc. (Nasdaq: CTKB), a leader in high-resolution cell analysis instrumentation, announced...
Nanobiotix S.A. (Euronext: NANO, NASDAQ: NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches for cancer and other serious...
